Kyverna cell therapy reportedly shows lasting autoimmune benefit
STAT reports that new data show many patients remained off other therapies a year after treatment.
TLDR
STAT reports that new data on Kyverna Therapeutics’ cell therapy show many patients remained off other therapies a year after treatment. The outlet describes the company as one step closer to launching the first cell therapy for an autoimmune disease.
Combined views
4.2K
2 Sources, first seen ago